Intrinsiqs

Is PROCEPT BioRobotics Corporation overvalued?

PROCEPT BioRobotics Corporation (PRCT) — key valuation metrics and fundamentals.

No verdict
Price
$17.25
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$981.9M
Dividend yield
0.0%
Return on equity
-30.6%
Sector
Healthcare

See the full interactive analysis →

Fair value compares PRCT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.